Activist investor Trian Fund Management plans to push Solventum to separate more of its businesses after the company’s $4.1 ...
Thermo Fisher’s release goes on to suggest that it believes it can more than double the profitability of Purification & Filtration under its corporate umbrella, relative to the business’ current ...
Trian Fund Management, which beneficially owns about 5% of Solventum (SOLV) and is the company’s largest active shareholder, commented on ...
M spin-off Solventum forecast annual profit above analyst estimates on Thursday, betting on strong sales of its wound care and surgical sterilization products.
Trian Fund Management, which beneficially owns ~5% of Solventum Corporation (SOLV) and is the company’s largest active shareholder, released an open letter and slide deck outlining its views on ...
Solventum faces significant challenges in its turnaround, including slow-growing core businesses, share loss, and margin ...
Despite Performance Declines Since Spinning Out of 3M, Trian Believes Solventum Has Potential to Drive Significant Improvements as a Standalone Company If Solventum Can Restore Performance to ...
Investing.com -- Activist investor Trian Fund Management is reportedly planning to urge Solventum to separate additional businesses following the company’s $4.1 billion deal to sell its filtration ...
Vontobel Holding Ltd. grew its holdings in Solventum Co. (NYSE:SOLV – Free Report) by 11.6% during the fourth quarter, ...
Rhumbline Advisers raised its holdings in Solventum Co. (NYSE:SOLV – Free Report) by 9.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange ...
Activist investor Nelson Peltz's Trian Fund Management plans to push Solventum for further business separations following the company's $4.1 billion filtration unit sale, the Wall Street Journal ...
Trian Fund Management, L.P. (“Trian”), which beneficially owns ~5% of Solventum Corporation (NYSE: SOLV) (“Solventum” or the “Company”) and is the Company’s largest active ...